Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -135,678 | -41,996 | -19,255 | -4,978 | N/A |
| Depreciation Amortization | 194 | -286 | -14 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,674 | -458 | 1,264 | 537 | N/A |
| Other Working Capital | 14,133 | -1,505 | 2,108 | 279 | N/A |
| Other Operating Activity | 2,644 | 1,409 | 1,812 | 387 | 0 |
| Operating Cash Flow | $-113,033 | $-42,836 | $-14,085 | $-3,775 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -181,503 | -26,030 | -11,532 | N/A | N/A |
| PPE Investments | -321 | -295 | N/A | N/A | N/A |
| Investing Cash Flow | $-181,824 | $-26,325 | $-11,532 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 61,207 | 50 | N/A |
| Common Stock Issued | 298,145 | 265 | 386 | N/A | N/A |
| Other Financing Activity | 0 | 92,838 | 0 | 7,069 | 0 |
| Financing Cash Flow | $298,145 | $93,103 | $61,593 | $7,119 | $N/A |
| Beginning Cash Position | 63,336 | 39,394 | 3,418 | 74 | N/A |
| End Cash Position | 66,624 | 63,336 | 39,394 | 3,418 | N/A |
| Net Cash Flow | $3,288 | $23,942 | $35,976 | $3,344 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -113,033 | -42,836 | -14,085 | -3,775 | N/A |
| Capital Expenditure | -321 | -295 | 0 | N/A | N/A |
| Free Cash Flow | -113,354 | -43,131 | -14,085 | -3,775 | 0 |